Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William S Denney

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Pathophysiology of Haemostasis and Thrombosis|January 25, 2006
Stochastic modeling of blood coagulation initiationKen Lo, William S Denney, Scott L Diamond
Journal of Pharmacokinetics and Pharmacodynamics|August 30, 2014
An updated Alzheimer's disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEMDaniela J Conrado, William S Denney, Danny Chen, et al.
Plos Computational Biology|October 14, 2010
Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human bloodManash S Chatterjee, William S Denney, Huiyan Jing, et al.
Cell Reports. Medicine|November 18, 2020
AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes PatientsAllegra Kaufman, Lubna Abuqayyas, William S Denney, et al.
Clinical Pharmacology in Drug Development|November 22, 2016
Glycemic Effect and Safety of a Systemic, Partial Glucokinase Activator, PF-04937319, in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin-A Randomized, Crossover, Active-Controlled StudyWilliam S Denney, Douglas S Denham, Michael R Riggs, et al.
British Journal of Clinical Pharmacology|September 14, 2016
Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjectsWilliam S Denney, Gabriele E Sonnenberg, Santos Carvajal-Gonzalez, et al.
Frontiers in Neuroscience|February 16, 2024
Pharmacokinetics and pharmacodynamics across infusion rates of intravenously administered nipocalimab: results of a phase 1, placebo-controlled studyJocelyn H Leu, An Vermeulen, Claudia Abbes, et al.
Blood|January 22, 2008
Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flowUzoma M Okorie, William S Denney, Manash S Chatterjee, et al.
Biotechnology and Bioengineering|April 1, 2006
Functional phenotyping of human plasma using a 361-fluorogenic substrate biosensing microarrayDhaval N Gosalia, William S Denney, Cleo M Salisbury, et al.
Journal of Clinical Pharmacology|March 19, 2025
Population Pharmacokinetics and Exposure-Response Analyses of Sarilumab in Patients with Polymyalgia RheumaticaChristine Xu, William S Denney, Ying Liu, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Pathophysiology of Haemostasis and Thrombosis|January 25, 2006
Stochastic modeling of blood coagulation initiationKen Lo, William S Denney, Scott L Diamond
Journal of Pharmacokinetics and Pharmacodynamics|August 30, 2014
An updated Alzheimer's disease progression model: incorporating non-linearity, beta regression, and a third-level random effect in NONMEMDaniela J Conrado, William S Denney, Danny Chen, et al.
Plos Computational Biology|October 14, 2010
Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human bloodManash S Chatterjee, William S Denney, Huiyan Jing, et al.
Cell Reports. Medicine|November 18, 2020
AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes PatientsAllegra Kaufman, Lubna Abuqayyas, William S Denney, et al.
Clinical Pharmacology in Drug Development|November 22, 2016
Glycemic Effect and Safety of a Systemic, Partial Glucokinase Activator, PF-04937319, in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin-A Randomized, Crossover, Active-Controlled StudyWilliam S Denney, Douglas S Denham, Michael R Riggs, et al.
British Journal of Clinical Pharmacology|September 14, 2016
Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjectsWilliam S Denney, Gabriele E Sonnenberg, Santos Carvajal-Gonzalez, et al.
Frontiers in Neuroscience|February 16, 2024
Pharmacokinetics and pharmacodynamics across infusion rates of intravenously administered nipocalimab: results of a phase 1, placebo-controlled studyJocelyn H Leu, An Vermeulen, Claudia Abbes, et al.
Blood|January 22, 2008
Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flowUzoma M Okorie, William S Denney, Manash S Chatterjee, et al.
Biotechnology and Bioengineering|April 1, 2006
Functional phenotyping of human plasma using a 361-fluorogenic substrate biosensing microarrayDhaval N Gosalia, William S Denney, Cleo M Salisbury, et al.
Journal of Clinical Pharmacology|March 19, 2025
Population Pharmacokinetics and Exposure-Response Analyses of Sarilumab in Patients with Polymyalgia RheumaticaChristine Xu, William S Denney, Ying Liu, et al.
Pageof 3